Vaccine News and Research

Latest Vaccine News and Research

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

In a new study, researchers tested the bi-, tri-, and tetravalent formulations of Newcastle disease virus (NDV)-based low-cost vaccine in mice.

29 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

A new study presented the findings of the Phase 3 trial of the Nanocovax coronavirus disease 2019 (COVID-19) vaccine.

29 Mar 2022

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.

29 Mar 2022

Is COVID-19 vaccination during pregnancy safe?

A new retrospective cohort study conducted across a large population of pregnant women in Ontario, Canada, has confirmed that the coronavirus disease 2019 (COVID-19) vaccination administered during pregnancy is not associated with any increased risk of adverse maternal or neonatal peripartum outcomes.

29 Mar 2022

One year after severe COVID-19, T cells persist against SARS-CoV-2

In a recently published article in the journal eBioMedicine, scientists have demonstrated that critically ill coronavirus disease 2019 (COVID-19) patients are capable of generating durable memory T cell response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than one year after hospital discharge.

28 Mar 2022

Virtual reality helps reduce COVID-19 vaccine hesitancy

A new study investigates whether intention for vaccination is increased by a gamified immersive VR experience that shows how community immunity works.

28 Mar 2022

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Researchers determine whether there was any reduction in the death rate in elderly COVID-19 patients following the second booster dose.

28 Mar 2022

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Researchers analyze the effect of prior infection, vaccination, and hybrid immunity against SARS-CoV-2 BA.1 and BA.2 Omicron subvariant infections.

28 Mar 2022

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Researchers investigate the risk of death following vaccination as compared to SARS-CoV-2 infection.

28 Mar 2022

COVID-19 vaccination continues to protect adults against severe illness and death

COVID-19 vaccination continues to help protect adults against severe illness with COVID-19, including hospitalizations and death, according to two reports released in today's MMWR.

28 Mar 2022

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

A new study assessed the dynamics of viral load of SARS-CoV-2 Omicron and Delta variants of concern post-vaccination and previous infection.

28 Mar 2022

Notable; The Future of Intelligent Automation in Healthcare

In this interview, we speak to Pranay Kapadia, CEO and co-founder at Notable, about their technology and its applications within healthcare.

From Notable 28 Mar 2022

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Researchers applied a previously developed thermostable self-amplifying ribonucleic acid vaccine to COVID-19.

28 Mar 2022

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

A recent study investigated the potency and functionality of T-cell and humoral responses against the SARS-CoV-2 wild-type strain and its variants.

28 Mar 2022

Study estimates protection against reinfection following primary SARS-CoV-2 infection

A recent study investigated the protection provided by the primary SARS-CoV-2 infection against reinfection.

28 Mar 2022

Benefits of heterotypic vaccination against variants of SARS-CoV-2

A new study evaluated the antibody responses against the newly emerged SARS-CoV-2 Omicron variant upon heterotypic vaccination in animal models.

28 Mar 2022

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Researchers designed a dynamic mathematical model to simulate the transmission of the SARS-CoV-2 Omicron variant in China and project its associated burden on healthcare facilities, should the zero-COVID-19 policy be lifted.

28 Mar 2022

Which U.S. cities are most vulnerable to spread of COVID-19?

Now, researchers from New Jersey City University have been attempting to explore the same factors to identify vulnerability in U.S. cities. Their research, under consideration at the journal Scientific Reports, is currently available on the Research Square* preprint server.

28 Mar 2022

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.

27 Mar 2022

Vaccine News and Research

Latest Vaccine News and Research

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Is COVID-19 vaccination during pregnancy safe?

One year after severe COVID-19, T cells persist against SARS-CoV-2

Virtual reality helps reduce COVID-19 vaccine hesitancy

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

COVID-19 vaccination continues to protect adults against severe illness and death

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Notable; The Future of Intelligent Automation in Healthcare

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Study estimates protection against reinfection following primary SARS-CoV-2 infection

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Which U.S. cities are most vulnerable to spread of COVID-19?

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in